The federal government shutdown has thrown a wrench into the works of the Food and Drug Administration. While food safety might not have been compromised, many of the agency’s more routine assignments are on hold and it may take months to catch up.
By Stephen Daniells, Hank Schultz and Adi Menayang
The year is new and many people are getting out their crystal balls. NutraIngredients-USA is no different, and here are five of our Top 10 big issues that will impact the dietary supplements industry in 2019.
While the Farm Bill has removed industrial hemp from Schedule I of the Controlled Substances Act, the use of CBD as an ingredient has many more hurdles to overcome especially with the FDA, according to attorney Todd A. Harrison.
China will not implement a new set of cross-border e-commerce (CBEC) regulations in January next year and will instead continue with existing regulations.
A new study has found that supplements marketed for weight loss and sports applications that contain the ingredient higenamine had widely varying and unpredictable dosages of this stimulant.
The European Commission (EC) has given the go-ahead to rename the carotenoid zeaxanthin currently listed in the novel foods register after an application by DSM Europe.
Much has been made of potential benefits of artificial intelligence (AI) for the discovery and development of new products and ever-growing interest in personalisation. However, AI has other benefits, says Cédric Bourges, founder and CEO of Nutraveris...
The confused picture on New Dietary Ingredients became a bit clearer this week when FDA updated the public docket on filings and said it does not expect there to be a significant change in how many companies are choosing to go through the process.
A new research partnership between Canadian CRO Nutrasource and a Florida medical clinic will aid the formulators of CBD products by providing baseline data that at the moment is lacking, an executive said.
Long-awaited guidance from the FDA spelling out which isolated or synthetic non-digestible carbohydrates it believes should be classified as ‘dietary fiber’ on the Nutrition Facts panel brings to an end a period of extended uncertainty for companies supplying...
Algatechnologies has launched Fucovital, a fucoxanthin oleoresin produced and extracted from microalgae, available in the US and Japan with launches in other markets to follow.
Nootropics is an area of the dietary supplement industry burgeoning with new ingredients. But at the ragged fringe of the category are drug-like substances that just won’t go away.
A recent sharp drop in the number of NDI Notifications filed with FDA has industry stakeholders scratching their heads and serves to shine a spotlight on the continuing uncertainty surrounding the present system for bringing new ingredients to market.
